Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Charles Rabkin

BCL2 Translocations in Healthy Individuals

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Blanche Alter

Inherited bone marrow failure syndromes study

Sarcoma Trachea, bronchus and lung Pancreas Other pharynx Oesophagus Nasopharynx Multiple myeloma and immunoproliferative diseases Liver and intrahepatic bile ducts Lip, oral cavity Leukaemia Larynx Cervix uteri Breast Brain, nervous system

Nikhil C Munshi

Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ralph D Sanderson

Novel Heparanase Inhibitors for Cancer Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Alan K Lichtenstein

Sensitivity of multiple myeloma cells to mTOR inhibitors

Multiple myeloma and immunoproliferative diseases

Multiple Myeloma Study / Histological Classification and Clinical Course of Surface Epithelial Ovarian Tumors in Abuja

Ovary Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology